Diagnosis, grading, and treatment recommendations for children, adolescents, and young adults with sinusoidal obstructive syndrome: an international expert position statement
Kris M. Mahadeo(Duke University), Selim Corbacioglu(Unknown), Krzysztof Kałwak(Poznan University of Medical Sciences), Sherwin S. Chan(Children's Mercy Hospital), Leslie Lehmann(Harvard University), Priti Tewari(The University of Texas MD Anderson Cancer Center), Jerelyn Moffet(Duke University), Avis Harden(The University of Texas MD Anderson Cancer Center), Paul G. Richardson(Harvard University), Sajad Khazal(The University of Texas MD Anderson Cancer Center), Shulin Li(The University of Texas MD Anderson Cancer Center), Jun‐ichi Abe(The University of Texas MD Anderson Cancer Center), Sung Won Choi(University of Michigan), Nicole D. Zantek(Purdue University West Lafayette), Basirat Shoberu(Albert Einstein College of Medicine), Jennifer Vittorio(NYU Langone Health), Partow Kebriaei(The University of Texas MD Anderson Cancer Center), Hisham Abdel‐Azim(University of Southern California), Katharina Kleinschmidt(University Hospital Regensburg), Jeffery J. Auletta(NHS Blood and Transplant), Francesco Paolo Tambaro(The University of Texas MD Anderson Cancer Center), Joseph Angelo(Baylor College of Medicine), Christine Duncan(Dana-Farber/Boston Children's Cancer and Blood Disorders Center), Jennifer McArthur(St. Jude Children's Research Hospital), Rajinder Bajwa(Nationwide Children's Hospital), Susan C. Abraham(Mayo Clinic), Keri Schadler(The University of Texas MD Anderson Cancer Center)
Cited by 82
Related Papers
A Phase 2 Study of Bortezomib in Relapsed, Refractory Myeloma
|New England Journal of Medicine|2003|2.6k
International uniform response criteria for multiple myeloma
|Leukemia|2006|2.6k
CRISPR-Cas9 Gene Editing for Sickle Cell Disease and β-Thalassemia
|New England Journal of Medicine|2020|1.8k
Lenalidomide after Stem-Cell Transplantation for Multiple Myeloma
|New England Journal of Medicine|2012|1.1k
Oral Ixazomib, Lenalidomide, and Dexamethasone for Multiple Myeloma
|New England Journal of Medicine|2016|1.1k